290 related articles for article (PubMed ID: 24901260)
1. Recent developments in novel antidepressants targeting α4β2-nicotinic acetylcholine receptors.
Yu LF; Zhang HK; Caldarone BJ; Eaton JB; Lukas RJ; Kozikowski AP
J Med Chem; 2014 Oct; 57(20):8204-23. PubMed ID: 24901260
[TBL] [Abstract][Full Text] [Related]
2. The nicotinic acetylcholine receptor as a target for antidepressant drug development.
Philip NS; Carpenter LL; Tyrka AR; Price LH
ScientificWorldJournal; 2012; 2012():104105. PubMed ID: 22619570
[TBL] [Abstract][Full Text] [Related]
3. Selective ligand behaviors provide new insights into agonist activation of nicotinic acetylcholine receptors.
Marotta CB; Rreza I; Lester HA; Dougherty DA
ACS Chem Biol; 2014 May; 9(5):1153-9. PubMed ID: 24564429
[TBL] [Abstract][Full Text] [Related]
4. Chemistry and pharmacology of nicotinic ligands based on 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol (AMOP-H-OH) for possible use in depression.
Kozikowski AP; Eaton JB; Bajjuri KM; Chellappan SK; Chen Y; Karadi S; He R; Caldarone B; Manzano M; Yuen PW; Lukas RJ
ChemMedChem; 2009 Aug; 4(8):1279-91. PubMed ID: 19569163
[TBL] [Abstract][Full Text] [Related]
5. Role of neuronal nicotinic acetylcholine receptors (nAChRs) on learning and memory in zebrafish.
Braida D; Ponzoni L; Martucci R; Sparatore F; Gotti C; Sala M
Psychopharmacology (Berl); 2014 May; 231(9):1975-85. PubMed ID: 24311357
[TBL] [Abstract][Full Text] [Related]
6. Cytisine-based nicotinic partial agonists as novel antidepressant compounds.
Mineur YS; Eibl C; Young G; Kochevar C; Papke RL; Gündisch D; Picciotto MR
J Pharmacol Exp Ther; 2009 Apr; 329(1):377-86. PubMed ID: 19164465
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, binding, and modeling studies of new cytisine derivatives, as ligands for neuronal nicotinic acetylcholine receptor subtypes.
Tasso B; Canu Boido C; Terranova E; Gotti C; Riganti L; Clementi F; Artali R; Bombieri G; Meneghetti F; Sparatore F
J Med Chem; 2009 Jul; 52(14):4345-57. PubMed ID: 19548687
[TBL] [Abstract][Full Text] [Related]
8. The contribution of α4β2 and non-α4β2 nicotinic acetylcholine receptors to the discriminative stimulus effects of nicotine and varenicline in mice.
de Moura FB; McMahon LR
Psychopharmacology (Berl); 2017 Mar; 234(5):781-792. PubMed ID: 28028600
[TBL] [Abstract][Full Text] [Related]
9. Differential modulation of brain nicotinic acetylcholine receptor function by cytisine, varenicline, and two novel bispidine compounds: emergent properties of a hybrid molecule.
Peng C; Stokes C; Mineur YS; Picciotto MR; Tian C; Eibl C; Tomassoli I; Guendisch D; Papke RL
J Pharmacol Exp Ther; 2013 Nov; 347(2):424-37. PubMed ID: 23959137
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests.
Andreasen JT; Olsen GM; Wiborg O; Redrobe JP
J Psychopharmacol; 2009 Sep; 23(7):797-804. PubMed ID: 18583432
[TBL] [Abstract][Full Text] [Related]
11. Chemical medicine: novel 10-substituted cytisine derivatives with increased selectivity for alpha4beta2 nicotinic acetylcholine receptors.
Kozikowski AP; Chellappan SK; Xiao Y; Bajjuri KM; Yuan H; Kellar KJ; Petukhov PA
ChemMedChem; 2007 Aug; 2(8):1157-61. PubMed ID: 17530728
[No Abstract] [Full Text] [Related]
12. Roles of nicotinic acetylcholine receptor beta subunits in function of human alpha4-containing nicotinic receptors.
Wu J; Liu Q; Yu K; Hu J; Kuo YP; Segerberg M; St John PA; Lukas RJ
J Physiol; 2006 Oct; 576(Pt 1):103-18. PubMed ID: 16825297
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiological perspectives on the therapeutic use of nicotinic acetylcholine receptor partial agonists.
Papke RL; Trocmé-Thibierge C; Guendisch D; Al Rubaiy SA; Bloom SA
J Pharmacol Exp Ther; 2011 May; 337(2):367-79. PubMed ID: 21285282
[TBL] [Abstract][Full Text] [Related]
14. Functions and pharmacology of α2β2 nicotinic acetylcholine receptors; in and out of the shadow of α4β2 nicotinic acetylcholine receptors.
Papke RL
Biochem Pharmacol; 2024 Jul; 225():116263. PubMed ID: 38735444
[TBL] [Abstract][Full Text] [Related]
15. The subunit composition and pharmacology of alpha-Conotoxin MII-binding nicotinic acetylcholine receptors studied by a novel membrane-binding assay.
Salminen O; Whiteaker P; Grady SR; Collins AC; McIntosh JM; Marks MJ
Neuropharmacology; 2005 Apr; 48(5):696-705. PubMed ID: 15814104
[TBL] [Abstract][Full Text] [Related]
16. In pursuit of alpha4beta2 nicotinic receptor partial agonists for smoking cessation: carbon analogs of (-)-cytisine.
Coe JW; Vetelino MG; Bashore CG; Wirtz MC; Brooks PR; Arnold EP; Lebel LA; Fox CB; Sands SB; Davis TI; Schulz DW; Rollema H; Tingley FD; O'Neill BT
Bioorg Med Chem Lett; 2005 Jun; 15(12):2974-9. PubMed ID: 15908213
[TBL] [Abstract][Full Text] [Related]
17. Neuronal Nicotinic Acetylcholine Receptor Modulators Reduce Sugar Intake.
Shariff M; Quik M; Holgate J; Morgan M; Patkar OL; Tam V; Belmer A; Bartlett SE
PLoS One; 2016; 11(3):e0150270. PubMed ID: 27028298
[TBL] [Abstract][Full Text] [Related]
18. A robust homogeneous binding assay for alpha4beta2 nicotinic acetylcholine receptor.
Hui X; Gao J; Xie X; Suto N; Ogiku T; Wang MW
Acta Pharmacol Sin; 2005 Oct; 26(10):1175-80. PubMed ID: 16174432
[TBL] [Abstract][Full Text] [Related]
19. Structural characterization of binding mode of smoking cessation drugs to nicotinic acetylcholine receptors through study of ligand complexes with acetylcholine-binding protein.
Rucktooa P; Haseler CA; van Elk R; Smit AB; Gallagher T; Sixma TK
J Biol Chem; 2012 Jul; 287(28):23283-93. PubMed ID: 22553201
[TBL] [Abstract][Full Text] [Related]
20. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.
Riganti L; Matteoni C; Di Angelantonio S; Nistri A; Gaimarri A; Sparatore F; Canu-Boido C; Clementi F; Gotti C
Br J Pharmacol; 2005 Dec; 146(8):1096-109. PubMed ID: 16273122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
